Failure to thrive secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) Created page with "__NOTOC__ {{Failure to thrive}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective measures for th..." |
Homa Najafi (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Failure to thrive}} | {{Failure to thrive}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Akash}} | ||
==Overview== | ==Overview== |
Revision as of 15:45, 22 August 2020
Failure to thrive Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Failure to thrive secondary prevention On the Web |
American Roentgen Ray Society Images of Failure to thrive secondary prevention |
Risk calculators and risk factors for Failure to thrive secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]